Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma

BACKGROUND: Recent evidence increasingly suggests key roles for the tricarboxylic acid cycle and fatty acid metabolism in tumor progression and metastasis. Aconitase 2 (ACO2) is a component of the tricarboxylic acid cycle and represents a key cellular metabolic hub that promotes de novo fatty acid b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Zheng, Wanqun, Chen, Zhen, Wu, Shilun, Chang, Haoxiao, Cai, Ming, Cai, Heping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748622/
https://www.ncbi.nlm.nih.gov/pubmed/36531056
http://dx.doi.org/10.3389/fonc.2022.1055376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748622/
https://www.ncbi.nlm.nih.gov/pubmed/36531056
http://dx.doi.org/10.3389/fonc.2022.1055376

Ejemplares similares